AllStar Health Brands (OTC Pink: ALST) has opted to issue a shareholder update as there are a number of initiatives that are now coming to fruition. ALST has formed a strategic partnership with Virotek Biosciences Inc., to facilitate the application of the rapid COVID test to the various AllStar commercial, industrial and civic customers. Agreeing to regular testing appears to be one of the alternatives that some employers will accept in place of double dose vaccine. This opens the way for services such as the ALST- Virotek partnership to complete those tests.